Our results suggest that the cDNA fragment analysis of FLT3-ITD mutation by capillary electrophoresis is an easy-to-implement technique that could be a useful alternative approach in patients with AML at diagnosis, during allo-HSCT monitoring and in post-FLT3i follow-up. This evidence concerns the gene FLT3 and acute myeloid leukemia.